Recorded Chinese product: 硫酸新霉素滴眼液硫酸新霉素滴眼液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

新霉素是一种在国家药监局注册认定的药品。该药品含有相关活性成分。

该药品关联的活性成分包括:新霉素Xinmei Su。这些成分信息来自国家药监局数据库。

您可以探索含有相同成分的其他药品:新霉素-137386d4成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 硫酸新霉素滴眼液) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.

Active ingredients associated with this product: 新霉素Xinmei Su.

Explore other medicines containing the same ingredient: 新霉素 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 硫酸新霉素滴眼液Recorded Chinese product: 硫酸新霉素滴眼液
  • 剂型Dosage form: 滴眼剂Eye drops
  • 规格Specification: 8ml :4万单位Recorded Chinese description: 8ml :4万单位

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 沧州光明药业有限公司Chinese legal name: 沧州光明药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H13020161

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H13020161

Manufacturer

Chinese legal name: 沧州光明药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H13020161

生产企业

沧州光明药业有限公司(国产)

适应症

本品适于由敏感葡萄球菌属(甲氧西林敏感金葡萄和凝固酶阴性葡萄球菌)、流感嗜血杆菌、大肠埃希菌、变形杆菌属等敏感革兰阴性杆菌所致结膜炎、泪囊炎、角膜炎、眼睑炎、睑板腺炎等。

用法用量

滴入眼结膜囊内,一次1~2滴,一日3~5次。

不良反应

偶有眼部轻度刺激不适,无全身不良反应。

禁忌

对新霉素或其他氨基糖苷类抗生素过敏的患者禁用。

注意事项

1??本品不得直接注入球结膜下或眼前房内。
2??泪囊感染(泪囊炎)常发生于泪囊管闭塞的儿童,除用本品滴眼外,可同时辅以局部热敷。
3??滴眼时瓶口勿接触眼睛,使用后将瓶盖拧紧,以免污染药液。

贮藏

遮光,密闭,在凉处保存。

规格

8ml :4万单位

证据Evidence

  • 批准文号: 国药准字H13020161
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.